PortfoliosLab logoPortfoliosLab logo
ASND vs. LEGR
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ASND vs. LEGR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ascendis Pharma A/S (ASND) and First Trust Indxx Innovative Transaction & Process ETF (LEGR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ASND achieves a 24.54% return, which is significantly higher than LEGR's 9.42% return.


ASND

1D
0.13%
1M
21.79%
6M
23.49%
YTD
24.54%
1Y
51.85%
3Y*
45.32%
5Y*
16.69%
10Y*
35.28%

LEGR

1D
0.44%
1M
-1.58%
6M
6.10%
YTD
9.42%
1Y
22.44%
3Y*
20.76%
5Y*
11.55%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ASND vs. LEGR - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
ASND
Ascendis Pharma A/S
24.54%54.89%9.31%3.13%-9.22%-19.34%19.88%122.06%15.65%
LEGR
First Trust Indxx Innovative Transaction & Process ETF
9.42%30.83%16.25%22.79%-19.01%17.91%18.73%27.99%-14.65%

Correlation

The correlation between ASND and LEGR is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Jan 25, 2018

0.28

Over the past year, the correlation between ASND and LEGR has dropped to 0.07 - well below their long-term average of 0.28, suggesting their price drivers have been diverging.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ASND vs. LEGR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASND
ASND Risk / Return Rank: 8383
Overall Rank
ASND Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
ASND Sortino Ratio Rank: 8181
Sortino Ratio Rank
ASND Omega Ratio Rank: 7878
Omega Ratio Rank
ASND Calmar Ratio Rank: 8686
Calmar Ratio Rank
ASND Martin Ratio Rank: 8989
Martin Ratio Rank

LEGR
LEGR Risk / Return Rank: 5555
Overall Rank
LEGR Sharpe Ratio Rank: 5757
Sharpe Ratio Rank
LEGR Sortino Ratio Rank: 5555
Sortino Ratio Rank
LEGR Omega Ratio Rank: 5454
Omega Ratio Rank
LEGR Calmar Ratio Rank: 5454
Calmar Ratio Rank
LEGR Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASND vs. LEGR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and First Trust Indxx Innovative Transaction & Process ETF (LEGR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ASNDLEGRDifference
Sharpe ratioReturn per unit of total volatility

-0.17

Sortino ratioReturn per unit of downside risk

-0.09

Omega ratioGain probability vs. loss probability

1.24

1.27

-0.03

Calmar ratioReturn relative to maximum drawdown

3.00

2.17

+0.83

Martin ratioReturn relative to average drawdown

9.09

7.42

+1.67

ASND vs. LEGR - Sharpe Ratio Comparison

The current ASND Sharpe Ratio is 1.38, which is comparable to the LEGR Sharpe Ratio of 1.56. The chart below compares the historical Sharpe Ratios of ASND and LEGR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ASND vs. LEGR - Drawdown Comparison

The maximum ASND drawdown since its inception was -61.72%, which is greater than LEGR's maximum drawdown of -36.12%. Use the drawdown chart below to compare losses from any high point for ASND and LEGR.


Loading charts...

Drawdown Indicators


ASNDLEGRDifference

Max Drawdown

Largest peak-to-trough decline

-61.72%

-36.12%

-25.60%

Max Drawdown (1Y)

Largest decline over 1 year

-17.62%

-10.40%

-7.22%

Max Drawdown (3Y)

Largest decline over 3 years

-29.15%

-14.25%

-14.90%

Max Drawdown (5Y)

Largest decline over 5 years

-60.46%

-31.45%

-29.01%

Max Drawdown (10Y)

Largest decline over 10 years

-61.72%

Current Drawdown

Current decline from peak

-4.19%

-4.10%

-0.09%

Average Drawdown

Average peak-to-trough decline

-18.79%

-6.57%

-12.22%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.77%

3.03%

+2.74%

Volatility

ASND vs. LEGR - Volatility Comparison

Ascendis Pharma A/S (ASND) has a higher volatility of 12.39% compared to First Trust Indxx Innovative Transaction & Process ETF (LEGR) at 4.09%. This indicates that ASND's price experiences larger fluctuations and is considered to be riskier than LEGR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ASNDLEGRDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.39%

4.09%

+8.30%

Volatility (6M)

Calculated over the trailing 6-month period

29.75%

12.41%

+17.34%

Volatility (1Y)

Calculated over the trailing 1-year period

38.25%

14.48%

+23.77%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.86%

17.09%

+31.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

51.11%

20.28%

+30.83%

Dividends

ASND vs. LEGR - Dividend Comparison

ASND has not paid dividends to shareholders, while LEGR's dividend yield for the trailing twelve months is around 1.83%.


PositionTTM20252024202320222021202020192018
ASND
Ascendis Pharma A/S
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LEGR
First Trust Indxx Innovative Transaction & Process ETF
1.83%1.84%2.40%2.56%2.64%1.80%0.95%2.04%1.30%

Frequently Asked Questions


ASND and LEGR have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ASND has higher volatility (12.39%) compared to LEGR (4.09%). In terms of maximum drawdown, ASND dropped -61.72% vs LEGR's -36.12%.

LEGR currently has the higher Sharpe Ratio (1.56 vs 1.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ASND and LEGR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer